Varex Imaging Future Growth
Future criteria checks 3/6
Varex Imaging is forecast to grow earnings and revenue by 147.5% and 3.5% per annum respectively while EPS is expected to grow by 147.4% per annum.
Key information
147.5%
Earnings growth rate
147.4%
EPS growth rate
Medical Equipment earnings growth | 12.4% |
Revenue growth rate | 3.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 13 Feb 2025 |
Recent future growth updates
Recent updates
Varex Imaging Corporation: A Mixed Picture
Jan 21Varex Imaging (NASDAQ:VREX) Is Finding It Tricky To Allocate Its Capital
Dec 19There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump
Nov 07Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?
Oct 22Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed
Sep 11Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings
Aug 20We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
May 10Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Feb 07We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
Dec 14Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Nov 05Is There Now An Opportunity In Varex Imaging Corporation (NASDAQ:VREX)?
Oct 29Varex Imaging (NASDAQ:VREX) Hasn't Managed To Accelerate Its Returns
Sep 27What Is Varex Imaging Corporation's (NASDAQ:VREX) Share Price Doing?
Jul 21These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Reasonably Well
Jun 15Is It Too Late To Consider Buying Varex Imaging Corporation (NASDAQ:VREX)?
Mar 25Varex Imaging Corporation's (NASDAQ:VREX) CEO Might Not Expect Shareholders To Be So Generous This Year
Feb 04Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Jan 31Returns On Capital At Varex Imaging (NASDAQ:VREX) Paint A Concerning Picture
Dec 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2027 | 914 | N/A | N/A | N/A | 2 |
9/30/2026 | 855 | 26 | 46 | 66 | 5 |
9/30/2025 | 827 | 10 | 24 | 43 | 5 |
1/3/2025 | 821 | -47 | 26 | 47 | N/A |
9/27/2024 | 811 | -48 | 20 | 47 | N/A |
6/28/2024 | 833 | 34 | 42 | 69 | N/A |
3/29/2024 | 856 | 42 | 72 | 98 | N/A |
12/29/2023 | 878 | 45 | 97 | 122 | N/A |
9/29/2023 | 893 | 48 | 88 | 108 | N/A |
6/30/2023 | 897 | 29 | 53 | 78 | N/A |
3/31/2023 | 880 | 29 | 13 | 38 | N/A |
12/30/2022 | 866 | 32 | -20 | 2 | N/A |
9/30/2022 | 859 | 30 | -4 | 17 | N/A |
7/1/2022 | 854 | 26 | 36 | 50 | N/A |
4/1/2022 | 851 | 30 | 60 | 75 | N/A |
12/31/2021 | 840 | 25 | 82 | 96 | N/A |
10/1/2021 | 818 | 17 | 78 | 93 | N/A |
7/2/2021 | 762 | -18 | 14 | 30 | N/A |
4/2/2021 | 722 | -58 | -8 | 9 | N/A |
1/1/2021 | 715 | -63 | -22 | -3 | N/A |
10/2/2020 | 738 | -58 | -10 | 13 | N/A |
7/3/2020 | 771 | -23 | 22 | 48 | N/A |
4/3/2020 | 796 | 4 | 37 | 63 | N/A |
1/3/2020 | 795 | 11 | 50 | 75 | N/A |
9/27/2019 | 781 | 16 | 52 | 72 | N/A |
6/28/2019 | 783 | 7 | 49 | 68 | N/A |
3/29/2019 | 778 | 13 | 52 | 73 | N/A |
12/28/2018 | 783 | 19 | N/A | 65 | N/A |
9/28/2018 | 773 | 28 | N/A | 85 | N/A |
6/29/2018 | 784 | 42 | N/A | 82 | N/A |
3/30/2018 | 763 | 49 | N/A | 87 | N/A |
12/29/2017 | 717 | 52 | N/A | 96 | N/A |
9/29/2017 | 698 | 52 | N/A | 75 | N/A |
6/30/2017 | 655 | 59 | N/A | 80 | N/A |
3/31/2017 | 636 | 66 | N/A | 80 | N/A |
12/30/2016 | 631 | 66 | N/A | 87 | N/A |
9/30/2016 | 620 | 69 | N/A | 74 | N/A |
7/1/2016 | 608 | 62 | N/A | 85 | N/A |
10/2/2015 | 632 | 80 | N/A | 85 | N/A |
9/26/2014 | 685 | 110 | N/A | 119 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VREX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: VREX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: VREX is expected to become profitable in the next 3 years.
Revenue vs Market: VREX's revenue (3.5% per year) is forecast to grow slower than the US market (8.5% per year).
High Growth Revenue: VREX's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VREX's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/02 20:10 |
End of Day Share Price | 2025/02/28 00:00 |
Earnings | 2025/01/03 |
Annual Earnings | 2024/09/27 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Varex Imaging Corporation is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kyle Bauser | B. Riley Securities, Inc. |
Lawrence Solow | CJS Securities, Inc. |
Rajbir Denhoy | Jefferies LLC |